Geode Capital Management, LLC Repligen Corp Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 921,419 shares of RGEN stock, worth $116 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

921,419

Previous 882,977 4.35%

Holding current value

$116 Million

Previous $159 Million 6.74%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $6.57 Million - $8.01 Million	38,442 Added 4.35%	921,419 $169 Million
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $3.51 Million - $5.7 Million	30,779 Added 3.61%	882,977 $159 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $2.49 Million - $3.16 Million	17,926 Added 2.15%	852,198 $136 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $6.74 Million - $8.78 Million	48,670 Added 6.2%	834,272 $118 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $3.99 Million - $5.12 Million	25,836 Added 3.4%	785,602 $132 Million

Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $7.4 Million - $10.1 Million	45,568 Added 6.38%	759,766 $128 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.24 Million - $1.98 Million	7,725 Added 1.09%	714,198 $134 Million
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $143,915 - $192,344	-1,023 Reduced 0.14%	706,473 $115 Million
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $4.04 Million - $6.46 Million	25,059 Added 3.67%	707,496 $133 Million
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $4.01 Million - $4.93 Million	16,198 Added 2.43%	682,437 $181 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $430,636 - $716,828	-2,211 Reduced 0.33%	666,239 $193 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $1.13 Million - $1.5 Million	6,800 Added 1.03%	668,450 $133 Million
Q1 2021 May 12, 2021	BUY	$180.37 - $226.26 $6.72 Million - $8.42 Million	37,235 Added 5.96%	661,650 $129 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $7.72 Million - $10.8 Million	52,121 Added 9.11%	624,415 $120 Million
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $2.34 Million - $3.02 Million	-19,067 Reduced 3.22%	572,294 $84.4 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $14.9 Million - $22.1 Million	-157,632 Reduced 21.05%	591,361 $73.1 Million
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $4.76 Million - $6.11 Million	56,001 Added 8.08%	748,993 $72.3 Million
Q4 2019 Feb 13, 2020	BUY	$73.84 - $93.08 $939,023 - $1.18 Million	12,717 Added 1.87%	692,992 $64.1 Million
Q3 2019 Nov 12, 2019	BUY	$76.65 - $95.51 $5.99 Million - $7.46 Million	78,152 Added 12.98%	680,275 $52.2 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $5.4 Million - $8.57 Million	99,697 Added 19.84%	602,123 $51.8 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $2.41 Million - $3.06 Million	48,727 Added 10.74%	502,426 $29.7 Million
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $2.13 Million - $3.04 Million	44,186 Added 10.79%	453,699 $23.9 Million
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $829,530 - $1.05 Million	17,725 Added 4.52%	409,513 $22.7 Million
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $866,267 - $1.16 Million	24,568 Added 6.69%	391,788 $18.4 Million
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $524,681 - $632,434	16,969 Added 4.84%	367,220 $13.3 Million
Q4 2017 Feb 13, 2018	BUY	$32.53 - $38.92 $459,258 - $549,472	14,118 Added 4.2%	350,251 $12.7 Million
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $788,413 - $981,999	21,320 Added 6.77%	336,133 $12.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	314,813	314,813 $13 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Repligen Corp Transaction History